Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
As CEO, my primary obligation is to the patients. While a 40% stock drop is a financial catastrophe, a cover-up that leads to preventable deaths is a corporate death sentence and a moral failure. If we "wait for more data" and another patient dies during that window, we move from "negligence" to "criminal intent."Read the full answer